Tragic shooting at Montana bar leads to capture of suspect with history of mental illness after week-long manhunt.
Colts QB Richardson's injury raises durability concerns as analysts criticize his decision-making.
Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making it a top performer in the S&P 500 and Nasdaq 100.
Tragic shooting at Montana bar leads to capture of suspect with history of mental illness after week-long manhunt.
Colts QB Richardson's injury raises durability concerns as analysts criticize his decision-making.
Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making it a top performer in the S&P 500 and Nasdaq 100.